A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for Asthma
30 locations incl. Montgomery
Sponsor: AstraZeneca
Sex: All·Age: 5 - 11
Code: NCT06023589·Phase 3·Recruiting